| Code | Description | Claims | Beneficiaries | Total Paid |
| 90837 |
Psychotherapy, 53 minutes with patient |
33,591 |
12,317 |
$2.75M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,934 |
10,903 |
$1.33M |
| H0038 |
Self-help/peer services, per 15 minutes |
11,877 |
1,622 |
$984K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
5,552 |
3,740 |
$906K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
11,683 |
7,081 |
$724K |
| T1017 |
Targeted case management, each 15 minutes |
1,294 |
876 |
$345K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
4,101 |
2,387 |
$246K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,649 |
3,952 |
$199K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
1,696 |
967 |
$166K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,199 |
1,188 |
$122K |
| 99205 |
Prolong outpt/office vis |
544 |
495 |
$87K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,979 |
2,282 |
$82K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,379 |
713 |
$59K |
| 99401 |
|
2,071 |
1,285 |
$59K |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
339 |
59 |
$45K |
| 90791 |
Psychiatric diagnostic evaluation |
352 |
270 |
$39K |
| 80305 |
|
688 |
359 |
$8K |
| 99215 |
Prolong outpt/office vis |
87 |
69 |
$7K |
| 90834 |
Psychotherapy, 45 minutes with patient |
88 |
55 |
$4K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
44 |
26 |
$4K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
93 |
43 |
$2K |
| 90785 |
|
18 |
18 |
$45.78 |